Women at Increased Risk for Heart Failure, Death After Myocardial Infarction
Women are at increased risk for heart failure and death after first-time myocardial infarction.
Women are at increased risk for heart failure and death after first-time myocardial infarction.
Cannabis users were found to have higher rates of acute myocardial infarction (AMI) and recurrent AMI compared with nonusers.
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
A reduced dose of prasugrel compared with the standard dose of ticagrelor was associated with maintained anti-ischemic efficacy and safety in elderly or low-weight patients with acute coronary syndrome.
The rates of myocardial infarction were found to decline during the COVID-19 pandemic, which also saw increases in sleep duration.
For patients with myocardial infraction, NSAID treatment is associated with a significantly increased risk for cardiovascular and bleeding events.
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
The use of percutaneous coronary intervention and coronary artery bypass grafting for the treatment of left main coronary artery disease of low or intermediate anatomic complexity was found to be associated with comparable rates of a composite of death, stroke, and myocardial infarction at 5 years.